James A. Schoeneck

2016 - DepoMed

In 2016, James A. Schoeneck earned a total compensation of $6.2M as Former President and Chief Executive Officer at DepoMed, a 3% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$694,000
Option Awards$2,308,415
Salary$787,500
Stock Awards$2,362,290
Other$14,865
Total$6,167,070

Schoeneck received $2.4M in stock awards, accounting for 38% of the total pay in 2016.

Schoeneck also received $694K in non-equity incentive plan, $2.3M in option awards, $787.5K in salary and $14.9K in other compensation.

Rankings

In 2016, James A. Schoeneck's compensation ranked 1,148th out of 14,075 executives tracked by ExecPay. In other words, Schoeneck earned more than 91.8% of executives.

ClassificationRankingPercentile
All
1,148
out of 14,075
92nd
Division
Manufacturing
388
out of 5,489
93rd
Major group
Chemicals And Allied Products
104
out of 1,895
95th
Industry group
Drugs
68
out of 1,538
96th
Industry
Pharmaceutical Preparations
56
out of 1,176
95th
Source: SEC filing on July 14, 2017.

Schoeneck's colleagues

We found five more compensation records of executives who worked with James A. Schoeneck at DepoMed in 2016.

2016

R Shively

DepoMed

Former Senior Vice President and Chief Commercial Officer

2016

Matthew Gosling

DepoMed

General Counsel

2016

August Moretti

DepoMed

Chief Financial Officer

2016

Srinivas Rao

DepoMed

Chief Medical Officer

2016

Thadd Vargas

DepoMed

Senior Vice President, Business Development

News

You may also like